We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

54 hedge funds and large institutions have $17.9M invested in Calithera Biosciences, Inc in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,533% more call options, than puts

Call options by funds: $139K | Put options by funds: $3K

0% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 12

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

2% less funds holding

Funds holding: 55 → 54 (-1)

34% less capital invested

Capital invested by funds: $27M → $17.9M (-$9.1M)

Holders
54
Holders Change
-1
Holders Change %
-1.82%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
12
Reduced
12
Closed
14
Calls
$139K
Puts
$3K
Net Calls
+$136K
Net Calls Change
-$45K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$941K
2
AAA
Affinity Asset Advisors
New York
+$511K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$511K
4
EAM
Empery Asset Management
New York
+$396K
5
Renaissance Technologies
Renaissance Technologies
New York
+$253K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$653K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$480K
3
AFM
Anson Funds Management
Texas
-$427K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$370K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$317K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$50K +$37.2K +3,643 +143%
B
27
Bailard
California
$49K +$62.5K +6,114 New
VF
28
Virtu Financial
New York
$44K -$63.2K -6,189 -53%
Wells Fargo
29
Wells Fargo
California
$42K -$613 -60 -1%
GCP
30
GSA Capital Partners
United Kingdom
$33K -$108K -10,530 -72%
Tudor Investment Corp
31
Tudor Investment Corp
Connecticut
$27K – – –
AI
32
Atom Investors
Texas
$27K +$11.1K +1,082 +47%
Group One Trading
33
Group One Trading
Illinois
$20K -$2.96K -290 -10%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$13K – – –
HF
35
HRT Financial
New York
$12K +$15.6K +1,522 New
FCA
36
FinTrust Capital Advisors
South Carolina
$10K – – –
Citigroup
37
Citigroup
New York
$10K +$13.2K +1,295 New
Morgan Stanley
38
Morgan Stanley
New York
$9K -$99K -9,687 -90%
KAS
39
Kestra Advisory Services
Texas
$8K – – –
TCM
40
Traynor Capital Management
Pennsylvania
$8K +$10.2K +1,000 New
SAM
41
Seelaus Asset Management
New Jersey
$7K – – –
TCA
42
Transcend Capital Advisors
New Jersey
$6K – – –
Cetera Investment Advisers
43
Cetera Investment Advisers
Illinois
$6K +$7.51K +735 New
Bank of America
44
Bank of America
North Carolina
$5K -$1.59K -156 -20%
GF
45
Gabelli Funds
New York
$5K – – –
HSBC Holdings
46
HSBC Holdings
United Kingdom
$5K – – –
Osaic Holdings
47
Osaic Holdings
Arizona
$4K +$7.66K +750 +1,667%
Simplex Trading
48
Simplex Trading
Illinois
$3K +$4.05K +396 New
Victory Capital Management
49
Victory Capital Management
Texas
$3K +$5.96K +583 New
UBS Group
50
UBS Group
Switzerland
$1K -$15.2K -1,485 -93%
1
2
3

CALA Hedge Fund Activity: Q1 2022 in Review

54 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q1 2022, worth a combined $17.9M — down 34% from $27M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CALA and 13 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 12 added.

The largest buyer was BVF Inc, adding an estimated $941K. The largest seller was D.E. Shaw & Co, cutting an estimated $653K.

  • 54 institutional investors held Calithera Biosciences, Inc (CALA) as of Q1 2022, down from 55 in Q4 2021.
  • Funds reported $17.9M of Calithera Biosciences, Inc stock for Q1 2022, down 34% quarter-over-quarter.
  • 13 funds opened new Calithera Biosciences, Inc positions in Q1 2022 and 14 closed out, a net change of -1 holder.
  • The largest Calithera Biosciences, Inc buyer in Q1 2022 was BVF Inc, an estimated $941K added.
  • The largest Calithera Biosciences, Inc seller in Q1 2022 was D.E. Shaw & Co, an estimated $653K sold.

Based on aggregated 13F filings for Q1 2022.